Medtelligence

Examining LDL Cholesterol and Our Growing Therapy Options in Primary Prevention

Examining LDL Cholesterol and Our Growing Therapy Options in Primary Prevention
RestartResume

Leaders in lipid management examine global CVD risk, the role of LDL-C reduction as first-line therapy, statin adherence, new options, and more.

  • Overview

    Professor Stephen Nicholls, Director of MonashHeart in Melbourne, Australia, and Professor Kausik Ray, Director of the Imperial Centre for Cardiovascular Disease Prevention in London, UK, engage in a stimulating discussion on issues of high interest in atherosclerotic cardiovascular disease (ASCVD) prevention. Topics include CVD risk worldwide, first-line therapy approaches with LDL-C reduction, key lipid management challenges, statin adherence, and new LDL-lowering options, all with useful guidance to consider.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free